# BUPROPION HYDROCHLORIDE
> **ANDA206122** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2016-08-17
## Drug
- **FDA Application Number:** ANDA206122
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPROPION HYDROCHLORIDE
- **Generic name:** BUPROPION HYDROCHLORIDE
- **Active ingredients:** BUPROPION HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc.
- **First approval:** 2016-08-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206122)
---
*MORVS · CC0 1.0*